Results 171 to 180 of about 2,249,136 (280)
ABSTRACT Aims Semaglutide, a glucagon‐like peptide‐1 (GLP‐1) receptor agonist, is approved for cardiovascular risk reduction in individuals with overweight or obesity and cardiovascular disease. Whether tirzepatide, a dual GLP‐1 and glucose‐dependent insulinotropic polypeptide receptor agonist, has similar cardiovascular benefits remains unknown.
Gwen Aubrac +5 more
wiley +1 more source
Serial bioelectrical impedance changes during nutritional follow-up in chronic pancreatitis. [PDF]
Lodola I +5 more
europepmc +1 more source
Equine gastric ulcer syndrome in foals
Summary Equine gastric ulcer syndrome (EGUS) in foals comprises equine squamous gastric disease (ESGD), equine glandular gastric disease (EGGD) and gastroduodenal ulcer disease (GDUD). While there are some similarities between ESGD and EGGD in foals compared to adult horses, there are also important age‐related differences that must be considered, and ...
A. L. Lovett +2 more
wiley +1 more source
All-cause and cause-specific mortality in chronic pancreatitis: A systematic review. [PDF]
Jiang Y +10 more
europepmc +1 more source
ABSTRACT Background and Aims Patients with chronic hepatitis C and advanced fibrosis remain at substantial risk of hepatocellular carcinoma (HCC) and non‐liver–related death even after sustained virological response (SVR) to direct‐acting antivirals (DAA).
Daisuke Sakon +19 more
wiley +1 more source
Abstract Background Recent European Society of Clinical Microbiology and Infection and Australasian Society of Infectious Diseases Clostridioides difficile infection (CDI) management guidelines endorse the addition of intravenous tigecycline in patients who are progressing to fulminant infection.
Emma Bishop +5 more
wiley +1 more source
Abstract Objectives Stigmatising language about patients with substance use disorders (SUD) is common in healthcare settings and negatively impacts patient care. Addiction consult services are associated with improved clinician attitudes and less stigmatising views towards patients with SUD.
Ryder Cuppett +3 more
wiley +1 more source
Abstract Chronic kidney disease (CKD) and cardiovascular disease (CVD) are major causes of morbidity and mortality in people with type 2 diabetes (T2D). Contemporary CKD guidelines increasingly support incorporation of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) as an additional pillar of cardiorenal therapy alongside renin–angiotensin ...
Eugenia Pedagogos +5 more
wiley +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Nadine Larissa Fergen +4 more
wiley +1 more source
Exploring Long‐Term Outcomes in Sepsis Survivors: A Prospective Cohort Study Across Acute Hospitals
ABSTRACT Introduction While sepsis survival rates have improved, long‐term consequences remain under‐recognised and support services limited. Survivors often face persistent physical, cognitive and psychological impairments that diminish their quality of life.
Katie O'Byrne +9 more
wiley +1 more source

